BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14975509)

  • 1. EBV-associated neoplasms: alternative pathogenetic pathways.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Med Hypotheses; 2004; 62(3):387-91. PubMed ID: 14975509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
    Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
    Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
    Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
    Ambinder RF
    Hematol Oncol Clin North Am; 1990 Aug; 4(4):821-33. PubMed ID: 2172203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt lymphoma--a stalking horse for cancer research?
    Klein G
    Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphomas associated with immunodeficiency states.
    Biemer JJ
    Ann Clin Lab Sci; 1990; 20(3):175-91. PubMed ID: 2188564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW
    Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
    Timms JM; Bell A; Flavell JR; Murray PG; Rickinson AB; Traverse-Glehen A; Berger F; Delecluse HJ
    Lancet; 2003 Jan; 361(9353):217-23. PubMed ID: 12547545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus in Hodgkin's disease.
    Chapman AL; Rickinson AB
    Ann Oncol; 1998; 9 Suppl 5():S5-16. PubMed ID: 9926231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
    IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of EBV in microRNA dysregulation in Burkitt lymphoma.
    De Falco G; Antonicelli G; Onnis A; Lazzi S; Bellan C; Leoncini L
    Semin Cancer Biol; 2009 Dec; 19(6):401-6. PubMed ID: 19619656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.